Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label multicenter study of Polygynax in mycotic and/or bacterial vaginitis
2008-007874-39Phase 4Completed
- Sponsor
- InnoTech Precision Medicine
- Start
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of nystatin + neomycin + polymyxin B in bacterial vaginosis (BV) and vaginitis, sponsored by InnoTech Precision Medicine. Primary endpoint: Clinical efficacy by investigator assessment. Started Feb 2009; status: completed.
02
Drugs
nystatin + neomycin + polymyxin B
03
Conditions
bacterial vaginosis (BV)vaginitis
Beyond the preview
Go deeper on 2008-007874-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007874-39.